Polar Asset Management Partners Inc. 13D and 13G filings for AEON Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-14 4:44 pm Sale | 2024-12-31 | 13G | AEON Biopharma, Inc. AEON | Polar Asset Management Partners Inc. | 38,371 6.900% | -12,671 (-24.82%) | Filing |
| 2024-02-14 1:46 pm Purchase | 2023-12-31 | 13G | AEON Biopharma, Inc. AEON | Polar Asset Management Partners Inc. | 51,042 9.900% | 51,042 (New Position) | Filing |